Evaluation of Tobramycin Exposure Predictions in Three Bayesian Forecasting Programmes Compared with Current Clinical Practice in Children and Adults with Cystic Fibrosis-Reference-Cited by-同舟云学术

Evaluation of Tobramycin Exposure Predictions in Three Bayesian Forecasting Programmes Compared with Current Clinical Practice in Children and Adults with Cystic Fibrosis

Published:2017-11-13 Issue:8 Volume:57 Page:1017-1027
ISSN:0312-5963
Container-title:Clinical Pharmacokinetics
language:en
Short-container-title:Clin Pharmacokinet

Author:

Burgard Marc,Sandaradura Indy^ORCID,van Hal Sebastiaan J.,Stacey Sonya^ORCID,Hennig Stefanie^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/article/10.1007/s40262-017-0610-9/fulltext.html

Reference31 articles.

1. Ratjen F, Brockhaus F, Angyalosi G. Aminoglycoside therapy against Pseudomonas aeruginosa in cystic fibrosis: a review. J Cyst Fibros. 2009;8(6):361–9.

2. Craig WA, Ebert SC. Killing and regrowth of bacteria in vitro: a review. Scand J Infect Dis. 1990;Supplementum 74:63–70.

3. Llanos-Paez C, Hennig S, Staatz C. Population pharmacokinetic modelling, Monte Carlo simulation and semi-mechanistic pharmacodynamic modelling as tools to personalize gentamicin therapy. J Antimicrob Chemother. 2017;72(3):639–67.

4. Kashuba ADM, Nafziger AN, Drusano GL, Bertino JS. Optimizing aminoglycoside therapy for nosocomial pneumonia caused by gram-negative bacteria. Antimicrob Agents Chemother. 1999;43(3):623–9.

5. Antibiotic Expert Group. Therapeutic Guidelines: Antibiotic. Version 15. Melbourne, VIC: Therapeutic Guidelines Ltd; 2014.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Significance of Bayesian Pharmacokinetics in Dosing for Critically Ill Patients: A Primer for Clinicians Using Vancomycin as an Example;Antibiotics;2023-09-13

2. Therapeutic drug monitoring-guided dosing for pediatric cystic fibrosis patients: recent advances and future outlooks;Expert Review of Clinical Pharmacology;2023-07-21

3. Implementation and Cross-Validation of a Pharmacokinetic Model for Precision Dosing of Busulfan in Hematopoietic Stem Cell Transplanted Children;Pharmaceutics;2022-10-01

4. Pharmacokinetic modelling to predict risk of ototoxicity with intravenous tobramycin treatment in cystic fibrosis;Journal of Antimicrobial Chemotherapy;2021-08-11

5. Individualized precision dosing approaches to optimize antimicrobial therapy in pediatric populations;Expert Review of Clinical Pharmacology;2021-08-06